Current status of robotic surgery for hepato-pancreato-biliary malignancies.
| Autor: | Bahra M; Zentrum für Onkologische Oberbauchchirurgie und Robotik, Krankenhaus Waldfriede, Akademisches Lehrkrankenhaus der Charité, Berlin, Germany., Ossami Saidy RR; Zentrum für Onkologische Oberbauchchirurgie und Robotik, Krankenhaus Waldfriede, Akademisches Lehrkrankenhaus der Charité, Berlin, Germany. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Expert review of anticancer therapy [Expert Rev Anticancer Ther] 2022 Sep; Vol. 22 (9), pp. 939-946. Date of Electronic Publication: 2022 Jul 26. |
| DOI: | 10.1080/14737140.2022.2105211 |
| Abstrakt: | Introduction: Robotic surgery is an emerging aspect of gastrointestinal surgery. Hepato-pancreato-biliary surgery is currently being explored for a broad spectrum of indications, entities, and postoperative outcomes. Noninferiority and financial aspects are the focus of studies. In this review, the impact on oncological therapies is assessed. Areas Covered: An extensive literature review was conducted, and relevant studies and articles and reviews for robotic surgery in the field of hepato-pancreato-biliary surgery were examined. Special attention was given to the oncological aspects of robotic surgery and its possible impact on the therapy of malignant neoplasms. Expert Opinion: Robotic-assisted surgery for oncological indications is promising, in part, an established technique that has already shown its advantages in the last decade, although high-quality studies are missing. Upcoming experience must consider the oncological benefit and putative new indications in a rapidly changing field of anti-neoplastic regimens. Also, robotic surgery may possess the ability to accelerate digitalization and AI-based augmentation in this context. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|